Biosurfit is a Portuguese company focused on the development and manufacture of IVD (in vitro diagnostics) tests at the Point-of-Care with highly innovative proprietary technology.
Biosurfit developed the spinit® technology, the first and only, diagnostics system capable of performing the major PoC blood test modalities (hematology, immunoassays and clinical chemistry) on the same instrument.
Total Amount: 10M€
200M Fund Amount: 5M€
Co-investors: Boule Diagnostics AB
Stage: Series A
Investment Date: December.2018